Checkpoint Therapeutics buy krebskrebs
Start price
21.02.22
/
50%
€1.69
Target price
21.02.23
€2.50
Performance (%)
-70.34%
End price
22.02.23
€0.50
Summary
This prediction ended on 22.02.23 with a price of €0.50. The BUY prediction by krebskrebs for Checkpoint Therapeutics performed very badly with a performance of -70.34%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Checkpoint Therapeutics | - | - | - |
iShares Core DAX® | -1.042% | 2.220% | 14.279% |
iShares Nasdaq 100 | -1.361% | 3.207% | 26.657% |
iShares Nikkei 225® | -0.044% | -1.680% | 5.941% |
iShares S&P 500 | -0.480% | 2.165% | 23.067% |
Comments by krebskrebs for this prediction
In the thread Checkpoint Therapeutics diskutieren
Buy mit Kursziel 2,5
In the thread Trading Checkpoint Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten